SG Americas Securities’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
Other funds holding ENZ
HFA
RAM
EGA
VCA
SG Americas Securities's ENZ Position: Q2 2021 in Review
SG Americas Securities sold out of Enzo Biochem, Inc. (ENZ) in Q2 2021, closing a stake of 14,819 shares — an estimated $51K sold.
SG Americas Securities first reported a position in ENZ in Q2 2014 and held it in 12 quarters. The position peaked at $181K in Q4 2017. 72 funds tracked by Wall St. Rank hold ENZ as of Q2 2021.
- SG Americas Securities reported no remaining Enzo Biochem, Inc. position as of Q2 2021 after selling out during the quarter.
- SG Americas Securities sold 14,819 Enzo Biochem, Inc. shares in Q2 2021, an estimated $51K.
- SG Americas Securities first reported a position in Enzo Biochem, Inc. in Q2 2014 and held it in 12 quarters.
- SG Americas Securities's Enzo Biochem, Inc. position peaked at $181K in Q4 2017.
- 72 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2021.
Based on SG Americas Securities's 13F filing for Q2 2021, filed 12 Aug 2021.